AMA Proposes Taxpayer-Funded $300K Uterus Transplants for Trans Women

The American Medical Association (AMA) proposed taxpayer-funded uterus transplants for transgender women to facilitate pregnancy and enhance their sense of being biological mothers.

The “Patient-Centered Transgender Surgical Care” issue of its Journal of Ethics presented recommendations to lower surgery expenses.

In June of this year, the AMA stated, “Even though there has been no uterus transplant to date in transwomen that we know of, some clinicians have maintained that there are no absolute barriers in anatomy, hormones and obstetric considerations that would rule out the possibility of successful UTx in transwomen.”

Yet, the AMA has faced persistent criticism for presenting this concept and has also been charged with adopting an “activist stance.”

They asserted that the inability of transgender women to conceive might result in “psychological dissonance,” potentially affecting their overall health and welfare.

The report emerges as certain pioneering uterus transplant specialists genuinely anticipate enabling transgender women to have biological children, although many individuals with knowledge of biology and other online users have expressed skepticism about the concept.

Similarly, Euro News, with a left-leaning perspective, also proposed that transgender women might achieve childbirth in the future.

Nonetheless, the instance cited by the outlet pertained to a procedure performed on a biological woman dealing with uterine factor infertility rather than a transgender woman.

The news organization said, “So far, births from uterus transplants have been in women assigned female at birth. But rapid advancements in the field have ignited hope among some transgender women about the possibility of pregnancy.”

The AMA argues that transgender women seeking to become pregnant could reasonably substantiate a uterus transplant funding of up to $300,000.

Dr. Marty Makary, a surgeon, professor and medical commentator at Johns Hopkins, known for expertise in surgical oncology and gastrointestinal laparoscopic surgery, conveyed his dissatisfaction with the association’s allocation of resources.

He highlighted that genuine transgender concerns, like the escalating health issues reported by individuals undergoing sex reassignment surgery and hormone therapy, remained unaddressed.

Makary said, “It is odd that the AMA is choosing to really focus on this activist position rather than fund the important research we need in transgender medicine. What’s the regret rate after transition surgery? What’s the long-term complication rate of hormones?”

In recent months, a group of physicians at the University of Alabama at Birmingham (UAB) pioneered the provision of the medical procedure to patients undergoing hysterectomies and women lacking wombs.

Notably, both of these categories encompassed biological females initially designated as such at birth.